Lawsuit Involving Invokana Side Effects Filed by Diabetes Patient Who Developed Life-Threatening Diabetic Ketoacidosis

April 28, 2016 – – TheProductLawyers.com comments on an Invokana lawsuit filed in the Southern District Of Alabama against Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson corporation), related specifically to diabetic ketoacidosis. It is a life-threatening condition that can develop very quickly and is when the body’s bloodstream contains a high level of ketones which can result in the patient suffering a diabetic coma or even death in the extreme case. The plaintiff in this case claims she began taking Invokana in December 2014 and developed ketoacidosis shortly thereafter.

Upon further review of the court papers it showed that the plaintiff also believed that the drug was not sufficiently studied over an adequate period of time and that it was marketed “off-label” to patients like her suffering from type 1 diabetes. She alleges that the manufacturer, despite the drug not being approved by the FDA for the treatment of type 1 diabetes, marketed the drug as a type 1 treatment anyway. She also claims that Janssen Pharmaceuticals did not clearly enunciate the potential adverse side effects of the drug to the public and were willfully negligent in its failure to do so.

The US Food and Drug Adminisration (FDA) issued a public safety warning about the drug and in it encouraged diabetes patients who are using Invokana or any other similar SGLT2 inhibitor drugs to be watchful of any potential symptoms that might emerge denoting the onset of ketoacidosis. The American Diabetes Association has reported on symptoms to be aware of such as excessive thirst or dry mouth, frequent urination, high blood sugar levels, high levels of ketones in the urine, difficulty breathing, pain in the abdomen, confusion fatigue, and nausea or vomiting.

The FDA, in its public safety report, also directed Janssen Pharmaceuticals to revise its warning label for Invokana to better address the potentially lethal side effect of the onset of diabetic ketoacidosis.

For more information about the Invokana lawsuits, or this press release, please contact TheProductLawyers.com on 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60009585